rna Archives - Page 3 of 5 -

News/ News/ R&D/ Top stories

Allergan bolsters aesthetics pipeline with Exicure hair loss deal

Phil Taylor Allergan, alopecia, dna, Exicure, rna 0 Comment

Allergan hasn’t pressed pause on business development in the build-up to its $63 billion buyout by AbbVie, and

Allergan bolsters aesthetics pipeline with Exicure hair loss deal

https://pharmaphorum.com/news/allergan-bolsters-aesthetics-unit-with-exicure-hair-loss-deal/

Partner content/ Press releases

Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020

Neill Howard rna, rna therapeutics 0 Comment

SMi Reports: RNA Therapeutics conference and focus day to return on February 2020, in London SMi Group is

Focus day announced for SMi’s 11th annual RNA Therapeutics conference 2020

https://pharmaphorum.com/partner-content/focus-day-announced-for-smis-11th-annual-rna-therapeutics-conference-2020/

Events/ Events/ Oncology

2nd RNA Targeted Drug Discovery Summit

jenna.warren@hansonwade.com Bristol-Myers Squibb, Eli Lilly, Pfizer, rna, small molecules 0 Comment

At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the 2nd RNA- Targeted Drug

2nd RNA Targeted Drug Discovery Summit

https://pharmaphorum.com/events/2nd-rna-targeted-drug-discovery-summit/

News/ News/ R&D

BMS looks to RNA splicing to boost immunotherapies

George Underwood BMS, Bristol-Myers Squibb, immunotherapy, Opdivo, rna, RNA splicing 0 Comment

Bristol-Myers Squibb’s quest to claim dominance in the immunotherapy space continues through a new collaboration with Eisai and

BMS looks to RNA splicing to boost immunotherapies

https://pharmaphorum.com/news/bms-looks-to-rna-splicing-to-boost-immunotherapies/

News/ News/ R&D

Dicerna agrees another gene-silencing deal, this time with Lilly

Phil Taylor Dicerna, Lilly, rna 0 Comment

Eli Lilly has agreed a broad collaboration with Dicerna, sealing the deal with a $100 million equity stake

Dicerna agrees another gene-silencing deal, this time with Lilly

https://pharmaphorum.com/news/dicerna-agrees-another-gene-silencing-deal-this-time-with-lilly/

Events/ Events/ Partner Content

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

Pavan Solanki dna, gene therapy, rna, rna therapeutics 0 Comment

RNA Therapeutics 2019

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

https://pharmaphorum.com/events/smis-10th-annual-rna-therapeutics-returns-this-february-2019/

Partner Content/ Partner content/ Press releases

The 10th Annual RNA Therapeutics Returns to London this Feb!

Pavan Solanki dna, gene editing, gene therapy, rna, rna therapeutics 0 Comment

RNA Therapeutics

The 10th Annual RNA Therapeutics Returns to London this Feb!

https://pharmaphorum.com/partner-content/the-10th-annual-rna-therapeutics-returns-to-london-this-feb/

Partner Content/ Partner content/ Press releases

A Run Down of Keynote Sessions for Cell & Gene Therapy 2018

Pavan Solanki cell, conference london, gene therapy, immunogenicity, rna 0 Comment

Cell and Gene Therapy

A Run Down of Keynote Sessions for Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/a-run-down-of-keynote-sessions-for-cell-gene-therapy-2018/

Partner content/ Press releases/ R&D

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

Pavan Solanki cell, gene therapy, genetics, genomics, rna 0 Comment

Cell & Gene Therapy 2018

Explore the latest developments in ATMPs at Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/explore-the-latest-developments-in-atmps-at-cell-gene-therapy-2018/

Trending

rna

Login